{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T21:14:53Z","timestamp":1771017293811,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1007\/s00405-005-0916-3","type":"journal-article","created":{"date-parts":[[2005,2,28]],"date-time":"2005-02-28T13:36:37Z","timestamp":1109597797000},"page":"890-898","source":"Crossref","is-referenced-by-count":47,"title":["Clinical and molecular prognostic factors in operable laryngeal cancer"],"prefix":"10.1007","volume":"262","author":[{"given":"Konstantinos","family":"Vlachtsis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelos","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Markou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Fountzilas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Daniilidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,3,1]]},"reference":[{"key":"916_CR1","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/00005537-200204000-00020","volume":"112","author":"Aaltonen","year":"2002","unstructured":"Aaltonen L M, Rihkanen H, Vaheri A (2002) Human papillomavirus in larynx. Laryngoscope 112:700\u2013707","journal-title":"Laryngoscope"},{"key":"916_CR2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<188::AID-IJC16>3.0.CO;2-1","volume":"84","author":"Almadori","year":"1999","unstructured":"Almadori G, Cadoni G, Galli J, Ferrandina G, Scambia G, Exarchakos G, Paludetti G, Ottaviani F (1999) Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor. Int J Cancer 84:188\u2013191","journal-title":"Int J Cancer"},{"key":"916_CR3","first-page":"3555","volume":"20","author":"Assimakopoulos","year":"2000","unstructured":"Assimakopoulos D, Kolettas E, Zagorianakou N, Evangelou A, Skevas A, Agnantis NJ (2000) Prognostic significance of p53 in the cancer of the larynx. Anticancer Res 20:3555\u20133564","journal-title":"Anticancer Res"},{"key":"916_CR4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1288\/00005537-199401000-00017","volume":"104","author":"Barra","year":"1994","unstructured":"Barra S, Barzan L, Maione A, Cadelano A, Pin M, Franceschi S, Comoretto R (1994) Blood transfusion and other prognostic variables in the survival of patients with cancer of the head and neck. Laryngoscope 104:95\u201398","journal-title":"Laryngoscope"},{"key":"916_CR5","doi-asserted-by":"crossref","unstructured":"Baselga J, Hammond LA (2002) HER-targeted tyrosine-kinase inhibitors. Oncology 63 [Suppl 1]:6\u201316","DOI":"10.1159\/000066198"},{"key":"916_CR6","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/oxfordjournals.aje.a009072","volume":"145","author":"Boffeta","year":"1997","unstructured":"Boffeta P, Merletti F, Faggiano F, Migliaretti G, Ferro G, Zanetti R, Terracini B (1997) Prognostic factors and survival of laryngeal cancer patients from Turin, Italy. A population-based study. Am J Epidemiol 145:1100\u20131105","journal-title":"Am J Epidemiol"},{"key":"916_CR7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1097-0347(199801)20:1<16::AID-HED3>3.0.CO;2-6","volume":"20","author":"Brasilino","year":"1998","unstructured":"Brasilino de Carvalho M (1998) Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx. Head Neck 20:16\u201321","journal-title":"Head Neck"},{"key":"916_CR8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00203395","volume":"427","author":"Bryne","year":"1995","unstructured":"Bryne M, Jenssen N, Boysen M (1995) Histological grading in the deep invasive front of T1 and T2 glottic squamous cell carcinomas has high prognostic value. Virchows Arch 427:277\u2013281","journal-title":"Virchows Arch"},{"key":"916_CR9","first-page":"4171","volume":"6","author":"Capone","year":"2000","unstructured":"Capone R, Pai S, Koch W, et al (2000) Detection and quantification of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res 6:4171\u20134175","journal-title":"Clin Cancer Res"},{"key":"916_CR10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s004050050120","volume":"256","author":"Carrillo","year":"1999","unstructured":"Carrillo JF, Frias-Mendivil M, Lopez-Graniel C, Beitia AI, Ochoa-Carrillo FJ (1999) The impact of preoperative tracheotomy on T3 transglottic carcinomas of the larynx. Eur Arch Otorhinolaryngol 256:78\u201382","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"916_CR11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/(SICI)1096-9896(199904)187:5<549::AID-PATH278>3.0.CO;2-O","volume":"187","author":"Codd","year":"1999","unstructured":"Codd JD, Salisbury JR, Packham G, Nicholson LJ (1999) A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma. J Pathol 187:549\u2013555","journal-title":"J Pathol"},{"key":"916_CR12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000027735","volume":"62","author":"Danic","year":"2000","unstructured":"Danic D, Maruic M, Uzarevic B, Milicic D (2000) Prognostic factors in squamous cell carcinoma of the larynx. ORL J Otorhinolaryngol Relat Spec 62:143\u2013148","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"916_CR13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0002-9610(89)90123-2","volume":"158","author":"Eiband","year":"1989","unstructured":"Eiband JD, Elias EG, Suter CM, Gray WC, Didolkar MS (1989) Prognostic factors in squamous cell carcinoma of the larynx. Am J Surg 158:314\u2013317","journal-title":"Am J Surg"},{"key":"916_CR14","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1056\/NEJMra001375","volume":"345","author":"Forastiere","year":"2001","unstructured":"Forastiere A, Koch W, Trotti A, Sidransky D (2001) Head and neck cancer. N Engl J Med 345:1890\u20131900","journal-title":"N Engl J Med"},{"key":"916_CR15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hed.10224","volume":"25","author":"Ford","year":"2003","unstructured":"Ford AC, Grandis JR (2003) Targeting epidermal growth factor receptor in head and neck cancer. Head Neck 25:67\u201373","journal-title":"Head Neck"},{"key":"916_CR16","first-page":"3445","volume":"8","author":"Geisler","year":"2002","unstructured":"Geisler S, Olsham A, Weissler M, et al (2002) p16 and p53 expression as prognostic indicators of survival and disease recurrence from head and neck cancer. Clin Cancer Res 8:3445\u20133453","journal-title":"Clin Cancer Res"},{"key":"916_CR17","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00405-003-0581-3","volume":"260","author":"Hardisson","year":"2003","unstructured":"Hardisson D (2003) Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 260:502\u2013508","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"916_CR18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0959-8049(98)00347-5","volume":"35","author":"Hirvikoski","year":"1999","unstructured":"Hirvikoski P, Kumpulainen E, Virtaniemi J, Pirinen R, Salmi L, Halonen P, Johansson R, Kosma VM (1999) Enhanced apoptosis correlates with poor survival in patients with laryngeal cancer but not with cell proliferation, bcl-2 or p53 expression. Eur J Cancer 35:231\u2013237","journal-title":"Eur J Cancer"},{"key":"916_CR19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/archotol.125.4.417","volume":"125","author":"Hotz","year":"1999","unstructured":"Hotz MA, Bosq J, Zbaeren P, Reed J, Schwab G, Krajewski S, Brousset P, Borner MM (1999) Spontaneous apoptosis and the expression of p53 and bcl-2 family proteins in locally advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 125:417\u2013422","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"916_CR20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<591::AID-CNCR9>3.0.CO;2-F","volume":"85","author":"Jackel","year":"1999","unstructured":"Jackel MC, Dorudian MA, Marx D, Brinck U, Schauer A, Steiner W (1999) Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression. Cancer 85:591\u2013599","journal-title":"Cancer"},{"key":"916_CR21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2273.2000.00318.x","volume":"25","author":"Jeannon","year":"2000","unstructured":"Jeannon JP, Soames J, Lunec J, Awwad S, Ashton V, Wilson JA (2000) Expression of cyclin-dependent kinase inhibitor p21(WAF1) and p53 tumour suppressor gene in laryngeal carcer. Clin Otolaryngol 25:23\u201327","journal-title":"Clin Otolaryngol"},{"key":"916_CR22","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2159::AID-CNCR10>3.0.CO;2-T","volume":"82","author":"Jin","year":"1998","unstructured":"Jin YT, Kayser S, Kemp BL, Ordonez NG, Tucker SL, Clayman GL, Goepfert H, Luna MA, Batsakis JG, El-Naggar AK (1998) The prognostic significance of the biomarkers p21WAF1\/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinoma. Cancer 82:2159\u20132165","journal-title":"Cancer"},{"key":"916_CR23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/jso.2930480204","volume":"48","author":"Kowalski","year":"1991","unstructured":"Kowalski LP, Franco EL, de Andrade Sobrinho J, Oliveira BV, Pontes PL (1991) Prognostic factors in laryngeal cancer patients submitted to surgical treatment. J Surg Oncol 48:87\u201395","journal-title":"J Surg Oncol"},{"key":"916_CR24","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1067\/mhn.2001.115498","volume":"124","author":"Lassaletta","year":"2001","unstructured":"Lassaletta L, Garcia-Pallares M, Morera E, Bernaldez R, Gavilan J (2001) T3 glottic cancer: oncologic results and prognostic factors. Otolaryngol Head Neck Surg 124:556\u2013560","journal-title":"Otolaryngol Head Neck Surg"},{"key":"916_CR25","first-page":"2089","volume":"22","author":"Lee","year":"2002","unstructured":"Lee DW, Sung MW, Park SW, Seong WJ, Roh JL, Park B, Heo DS, Kim KH (2002) Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs. Anticancer Res 22:2089\u20132096","journal-title":"Anticancer Res"},{"key":"916_CR26","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hed.10108","volume":"24","author":"Lin","year":"2002","unstructured":"Lin DT, Subbaramaiah K, Shah JP, Dannenberg AJ, Boyle JO (2002) Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer. Head Neck 24:792\u2013799","journal-title":"Head Neck"},{"key":"916_CR27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00405-003-0643-6","volume":"261","author":"Markou","year":"2004","unstructured":"Markou K, Vlachtsis K, Nikolaou A, Petridis D, Kouloulas A, Daniilidis I (2004) Incidence and predisposing factors of pharyngocutaneous fistula formation after total laryngectomy. Is there a relationship with tumor recurrence? Eur Arch Otorhinolaryngol 261:61\u201367","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"916_CR28","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/bjc.1996.525","volume":"74","author":"Maurizi","year":"1996","unstructured":"Maurizi M, Almadori G, Ferrandina G, Distefano M, Romanini ME, Cadoni G, Benedetti-Panici P, Paludetti G, Scambia G, Mancuso S (1996) Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 74:1253\u20131257","journal-title":"Br J Cancer"},{"key":"916_CR29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00405-003-0651-6","volume":"260","author":"Mielcarek-Kuchta","year":"2003","unstructured":"Mielcarek-Kuchta D, Olofsson J, Golusinski W (2003) p53, Ki67 and cyclin D1 as prognostic factors of lymph node metastases in laryngeal carcinoma. Eur Arch Otorhinolaryngol 260:549\u2013554","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"916_CR30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1054\/bjoc.2000.1357","volume":"83","author":"Mineta","year":"2000","unstructured":"Mineta H, Miura K, Ogino T, Takebayashi S, Misawa K, Ueda Y, Suzuki I, Dictor M, Borg A, Wennerberg J (2000) Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br J Cancer 83:775\u2013781","journal-title":"Br J Cancer"},{"key":"916_CR31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ijc.11055","volume":"105","author":"Modjtahedi","year":"2003","unstructured":"Modjtahedi H, Moscatello DK, Box G, Green M, Shotton C, Lamb DJ, Reynolds LJ, Wong AJ, Dean C, Thomas H, Eccles S (2003) Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti-EGFR MAb ICR62: a two-pronged attack for tumour therapy. Int J Cancer 105:273\u2013280","journal-title":"Int J Cancer"},{"key":"916_CR32","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0194-5998(98)70123-8","volume":"119","author":"Morales-Angulo","year":"1998","unstructured":"Morales-Angulo C, Val-Bernal F, Buelta L, Fernandez F, Garcia-Castrillo L, Rama J (1998) Prognostic factors in supraglottic laryngeal carcinoma. Otolaryngol Head Neck Surg 119:548\u2013553","journal-title":"Otolaryngol Head Neck Surg"},{"key":"916_CR33","doi-asserted-by":"crossref","unstructured":"Nakashima T, Wang XF, Masuda M, Inokuchi A, Komiyama S (1999) Overexpression of p53 nuclear protein in premelignant and malignant laryngeal lesions. Eur Arch Otorhinolaryngol 256 [Suppl 1]:S56\u201359","DOI":"10.1007\/PL00014155"},{"key":"916_CR34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/(SICI)1097-0142(19980115)82:2<286::AID-CNCR7>3.0.CO;2-P","volume":"82","author":"Narayana","year":"1998","unstructured":"Narayana A, Vaughan AT, Gunaratne S, Kathuria S, Walter SA, Reddy SP (1998) Is p53 an independent prognostic factor in patients with laryngeal carcinoma? Cancer 82:286\u2013291","journal-title":"Cancer"},{"key":"916_CR35","first-page":"3599","volume":"60","author":"Nathan","year":"2000","unstructured":"Nathan CA, Sanders K, Abreo FW, Nassar R, Glass J (2000) Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications. Cancer Res 60:3599\u20133604","journal-title":"Cancer Res"},{"key":"916_CR36","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1080\/00016489950180711","volume":"119","author":"Neuchrist","year":"1999","unstructured":"Neuchrist C, Quint C, Pammer A, Burian M (1999) Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: an immunohistochemical study. Acta Otolaryngol 119:732\u2013738","journal-title":"Acta Otolaryngol"},{"key":"916_CR37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/(SICI)1097-0347(199707)19:4<323::AID-HED11>3.0.CO;2-A","volume":"19","author":"Nicolai","year":"1997","unstructured":"Nicolai P, Redaelli de Zinis LO, Tomenzoli D, Barezzani MG, Bertoni F, Bignardi M, Antonelli AR (1997) Prognostic determinants in supraglottic carcinoma: univariate and Cox regression analysis. Head Neck 19:323\u2013334","journal-title":"Head Neck"},{"key":"916_CR38","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/1097-0142(20010801)92:3<556::AID-CNCR1355>3.0.CO;2-Q","volume":"92","author":"O-charoenrat","year":"2001","unstructured":"O-charoenrat P, Rhys-Evans P, Eccles S (2001) Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma corelates with lymph node metastasis. Cancer 92:556\u2013568","journal-title":"Cancer"},{"key":"916_CR39","first-page":"703","volume":"19","author":"Pulkkinen","year":"1999","unstructured":"Pulkkinen JO, Klemi P, Martikainen P, Grenman R (1999) Apoptosis in situ, p53, bcl-2 and AgNOR counts as prognostic factors in laryngeal carcinoma. Anticancer Res 19:703\u2013707","journal-title":"Anticancer Res"},{"key":"916_CR40","doi-asserted-by":"crossref","unstructured":"Ranson M (2002) ZD1839 (Iressa): for more than just non-small cell lung cancer. Oncologist 7 [Suppl 4]:16\u201324","DOI":"10.1634\/theoncologist.7-suppl_4-16"},{"key":"916_CR41","first-page":"1099","volume":"17","author":"Riedel","year":"2000","unstructured":"Riedel F, Gotte K, Schwalb J, Bergler W, Hormann K (2000) Expression of 92-kDa type IV collagenase correlates with angiogenesis markers and poor survival in head and neck squamous cell carcinoma. Int J Oncol 17:1099\u20131105","journal-title":"Int J Oncol"},{"key":"916_CR42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1365-2273.1998.00087.x","volume":"23","author":"Rowley","year":"1998","unstructured":"Rowley H, Roland NJ, Helliwell TR, Caslin A, Kinsella AR, Jones AS (1998) p53 protein expression in tumours from the head and neck subsites, larynx and hypopharynx, and differences in relationship to survival. Clin Otolaryngol 23:57\u201362","journal-title":"Clin Otolaryngol"},{"key":"916_CR43","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1177\/019459989010300523","volume":"103","author":"Rubin","year":"1990","unstructured":"Rubin J, Johnson JT, Myers EN (1990) Stomal recurrence after laryngectomy: interrelated risk factor study. Otolaryngol Head Neck Surg 103:805\u2013812","journal-title":"Otolaryngol Head Neck Surg"},{"key":"916_CR44","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/00005537-200006000-00024","volume":"110","author":"Sittel","year":"2000","unstructured":"Sittel C, Ecke HE, Damm M, von Pritzbuer E, Kvasnicka HM (2000) Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma. Laryngoscope 110:1012\u20131017","journal-title":"Laryngoscope"},{"key":"916_CR45","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/00005537-200106000-00028","volume":"111","author":"Spector","year":"2001","unstructured":"Spector JG, Sessions DG, Haughey BH, Chao KS, Simpson J, El Mofty S, Perez CA (2001) Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of larynx and hypopharynx. Laryngoscope 111:1079\u20131087","journal-title":"Laryngoscope"},{"key":"916_CR46","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/BF00181968","volume":"251","author":"Stankiewicz","year":"1994","unstructured":"Stankiewicz C (1994) Prognostic significance of lymph node reactivity in patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol 251:418\u2013422","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"916_CR47","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/archotol.1997.01900040048008","volume":"123","author":"Takes","year":"2002","unstructured":"Takes RP, Baatenburg de Jong RJ, Scuuring E, Hermans J, Vis AA, Litvinov SV, van Krieken JH (2002) Markers for assessment of nodal metastasis in laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 123:412\u2013419","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"916_CR48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s106-002-8063-2","volume":"50","author":"Weber","year":"2002","unstructured":"Weber A, Tannapfel A (2002) Prognosefactoren bei Kopf-Hals-karzinomen. HNO 50:35\u201342","journal-title":"HNO"},{"key":"916_CR49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/000348949510400701","volume":"104","author":"Welkoborsky","year":"1995","unstructured":"Welkoborsky HJ, Hinni M, Dienes HP, Mann WJ (1995) Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading, and proliferation markers. Ann Otol Rhinol Laryngol 104:503\u2013510","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"916_CR50","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hed.1089","volume":"23","author":"Yang","year":"2001","unstructured":"Yang HJ, Cho YJ, Kim HS, Chang MS, Sung MW, Kim WH (2001) Association of p53 and BCL-2 expression with Epstein-Barr virus infection in the cancers of head and neck. Head Neck 23:629\u2013636","journal-title":"Head Neck"},{"key":"916_CR51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0196-0709(98)90100-4","volume":"19","author":"Yilmaz","year":"1998","unstructured":"Yilmaz T, Hosal AS, Gedikoglu G, Onerci M, Gursel B (1998) Prognostic significance of vascular and perineural invation in cancer of the larynx. Am J Otolaryngol 19:83\u201388","journal-title":"Am J Otolaryngol"},{"key":"916_CR52","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00005537-199805000-00025","volume":"108","author":"Yilmaz","year":"1998","unstructured":"Yilmaz T, Hosal S, Gedikoglou G, Turan E, Ayas K (1998) Prognostic significance of depth of invasion in cancer of the larynx. Laryngoscope 108:764\u2013768","journal-title":"Laryngoscope"},{"key":"916_CR53","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0002-9610(96)00162-6","volume":"172","author":"Yuen","year":"1996","unstructured":"Yuen AP, Wei WI, Ho WK, Hui Y (1996) Risk factors of tracheostomal recurrence after laryngectomy for laryngeal carcinoma. Am J Surg 172:263\u2013266","journal-title":"Am J Surg"},{"key":"916_CR54","first-page":"4863","volume":"20","author":"Yuen","year":"2000","unstructured":"Yuen PW, Lam KY, Choy JT, Ho WT, Wei WI (2000) Clinicopathological significance of p53 and p21 expression in the surgical treatment of laryngeal carcinoma. Anticancer Res 20:4863\u20134866","journal-title":"Anticancer Res"},{"key":"916_CR55","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00005537-200301000-00031","volume":"113","author":"Vielba","year":"2003","unstructured":"Vielba R, Bilbao J, Ispizua A, et al (2003) p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Laryngoscope 113:167\u2013172","journal-title":"Laryngoscope"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-005-0916-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00405-005-0916-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-005-0916-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T18:00:59Z","timestamp":1559066459000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00405-005-0916-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,1]]},"references-count":55,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["916"],"URL":"https:\/\/doi.org\/10.1007\/s00405-005-0916-3","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,1]]}}}